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PartitionPeptide–membrane interactions have been gaining increased relevance, mainly in biomedical investigation, as
the potential of the natural, nature-based and synthetic peptides as new drugs or drug candidates also expands.
These peptides must face the cell membrane when they interfere with or participate in intracellular processes.
Additionally, several peptide drugs and drug leads actions occur at the membrane level (e.g., antimicrobial
peptides, cell-penetrating peptides and enveloped viruses membrane fusion inhibitors). Here we explore
ﬂuorescence spectroscopy methods that can be used to monitor such interactions. Two main approaches are
considered, centered either on the peptide or on the membrane. On the ﬁrst, we consider mainly the
methodologies based on the intrinsic ﬂuorescence of the aminoacid residues tryptophan and tyrosine. Regarding
membrane-centric approaches, we reviewmethods based on lipophilic probes sensitive tomembrane potentials.
The use of ﬂuorescence constitutes a simple and sensitive method to measure these events. Unraveling the
molecular mechanisms that govern these interactions can unlock the key to understand speciﬁc biological
processes involving natural peptides or to optimize the action of a peptide drug.crobial peptide; BPPZ, 3-(4-{4-
yridiniumyl)-1-propanesulfo-
ehydroergosterol; di-8-ANEPPS,
ulfopropyl)-pyridinium; DNS,
itoylphophatidylcholine; ESIPT,
-dimethylamino)-3-hydroxy-6-
, ﬂuorescein phosphatidyletha-
uman immunodeﬁciency virus;
; PC, phosphatidylcholine; PG,
idylcholine; POPG, 1-palmitoyl-
ction of dimensionality; RH421,
nyl]-pyridinium
+351 217999477.
ll rights reserved.© 2010 Elsevier B.V. All rights reserved.Contents1. Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1999
2. Quantiﬁcation of the partition of a peptide to a membrane using intrinsic ﬂuorescence . . . . . . . . . . . . . . . . . . . . . . . . . . 2001
2.1. Basic concept . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2001
2.2. Determination of Kp by intrinsic ﬂuorescence parameters . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2001
2.3. Complex partition curves . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2002
2.4. Adsorption quantiﬁcation by Förster Resonance Energy Transfer methodologies . . . . . . . . . . . . . . . . . . . . . . . . . . . 2003
3. Peptide–lipid interactions studied using membrane potential-sensitive probes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2005
3.1. Membrane surface potential perturbation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2005
3.2. Membrane dipole potential perturbation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2007
3.3. Transmembrane potential perturbation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2008
4. Conclusions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2010
Acknowledgments. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2010
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20101. Introduction
The interaction of peptides with lipid bilayers is attracting the
attention of a growing community of scientists. Innovative applications
of atomic force microscopy, NMR and ﬂuorescence spectroscopy [1], for
instance, allow detailed information on peptide conformation, orienta-
tion and association in the conﬁned space of the bilayer to be obtained.
Along with academic interest, industry (mainly pharmaceutical) has
been achieving important milestones on the development of peptide
products. Enfuvirtide (T-20) is a 36-aminoacid peptide HIV-1 fusion
inhibitor in clinical use. Other clinically relevant peptides may follow,
Fig. 1. Outline of peptide–membrane interactions. Peptides in contact with membranes
may change conformation, which may facilitate proper binding to a receptor. Peptides
may also exert local speciﬁc effects, such as disorder or permeabilization (e.g.,
antimicrobial peptides). Other peptides have the ability to translocate across the
membrane, having no apparent effect in the lipid bilayer. Reprinted from [10].
Fig. 2. Simpliﬁed scheme for membrane-mediated ligand–receptor interaction, where
no membrane binding sites are considered and partition is described by a single
equilibrium step. Kp and Kb are equilibrium constants for partition into the membrane
and binding to receptor, respectively (Lw refers to ligand L in the bulk aqueous phase;
Lm refers to ligand in the membrane; R — receptor). Reprinted from [10].
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system-targeted drugs [2–5]. In the long term, cell-penetrating peptides
(CPP) may also play an important role in gene therapy [6].
Many of the peptides that gather academic and industrial interest
are membrane-active (i.e., lipid-interactive) peptides (Fig. 1), but
while antimicrobial peptides (AMP) target bacterial membranes,
others (such as enfuvirtide [7,8]) may bind lipids in a pre-stage for
receptor docking. This concept was put forward in 1986 [9] and has
been reﬁned over the years (for a review see [10]). The lipid palisade
inﬂuences the peptide concentration, conformation, location, and
orientation in ways that improve peptide ligand–receptor interaction
relative to free solution. The ﬁrst conceptualization [9] considered the
docking of a ligand to amembrane receptor to be a three-step process:
(i) adsorption of the ligand to the membrane and formation of an
accumulation layer; (ii) insertion in the membrane for which binding
sites were considered to exist; and, (iii) receptor docking in the
membrane matrix. Whilst electrostatic accumulation in adsorption is
important, as shown by the fact that receptor-binding kinetics may be
105 times faster than in its absence [9], steady-state considerations
can be made clearer considering the bulk aqueous medium vs.
membrane concentration balance. Fig. 2 depicts the equilibria
involved in membrane-mediated ligand–receptor docking in a more
simpliﬁed way. Membrane insertion is accounted for in a single step
and no membrane binding sites for insertion are evoked, because this
membrane binding sites have an elusive physical counterpart. There
are however other frameworks that account for multi-step binding
processes of peptides to membranes, taking into account water–lipid
interfacial regions and also the folding of the peptide or protein itself
[11,12].
The concentrating effect of the membrane is expected to increase
the occupied-to-unoccupied receptor-binding sites ratio by a partition
coefﬁcient (Kp) factor (see below) that combines adsorption and
insertion in the lipid palisade [10]. The ratio of bound to unbound
receptors is:
LR½ m
R½ m
= KpKb L½ w ð1Þ
where [LR]m is the concentration of the ligand–receptor complex in
the membrane, [R]m is the concentration of the receptor in the
membrane, Kb is the binding constant and [L]w is the ligand
concentration in aqueous environment. In the absence of membranes,
the ratio of bound to unbound receptors would be Kb[L]w.
Typical moderate values of Kp are 103–104 in the absence of an
electrostatic contribution and 105–106 when an electrostatic attrac-tion is present [7,8,13]. Thus, the extent of ligand–receptor binding
can be improved up to several orders of magnitude. However, the
power of membranes to concentrate the ligand is not effective unless
receptor-binding site and ligand are located at the same depth in the
membrane. Three main methods exist to estimate the depth or depth
distribution of ﬂuorophores in the membrane. The Parallax Method
[14] adapts the common simple methodology of the three-dimen-
sional quenching sphere-of-action model to two dimensions. The
underlying concept of static (non-diffusive) quenching [15] remains
unchanged. This assumption conﬁnes the appropriate applicability of
themodel to few experimental cases, although it is often usedwithout
checking for this premise. The Distribution Analysis of Depth-
Dependent Fluorescent Quenching (Distribution Analysis, in short)
is an alternative that overcame these limitations [16]. For instance,
compared to the Parallax Method, the Distribution Analysis yields
additional valuable information on the ﬂuorophore's transverse
heterogeneity and lipid exposure and it can be used to evaluate
wide ranges of membrane penetrations [17]. A second alternative to
overcome some of the formal weaknesses of the Parallax Method [18]
applies the simple diffusional quenching concepts to the restricted
dimensionality of a bilayer, which is treated as a slab where
ﬂuorophores and quenchers locate, having a certain in-depth
distribution. Single-molecule Brownian Dynamics simulations were
carried out to ascertain the quencher statistical location distributions.
Pairs of quenchers (either brominated or doxyl-derivatized acyl
chains in fatty acids or phospholipids) are then used to quench the
ﬂuorophore. The relative degree of quenching between them depends
on the known distributions of the quenchers and on the ﬂuorophore
distribution to be determined. This methodology was applied to study
the location of the HIV fusion inhibitors enfuvirtide (T-20), T-1249
and sifuvirtide, which were proposed to use membrane-mediated
steps in theirmechanism of action [7,8,19]. A shallow average position
of the Trp residueswas determined, which helps to position thewhole
molecular ensemble in the lipid bilayer.
Along with concentration and conformation modulation, the most
important role of membranes is the modulation of the ligand
orientation. The most common spectroscopic methods used to
determine the orientation of foreign molecules in membranes were
reviewed in reference [20]. These include IR spectroscopy, UV–Vis
linear dichroism, time-resolved ﬂuorescence anisotropy decays,
Raman spectroscopy, Surface Plasmon Resonance and NMR. UV–Vis
linear dichroism methodologies have been applied in a large number
of studies involving different classes of molecules, including multi-
functional peptides [21,22].
An eventual advantage in membrane mediation relates to the
reduction of dimensionality from 3D to 2D. Adam and Delbrück [23]
theorized that reaction rates between ligands and surface bound
receptors would be increased by non-speciﬁc ligand adsorption and
2D diffusion towards receptors. This effect is referred to as reduction
of dimensionality (RD) reaction rate enhancement. Since then, several
theoretical models attempted to describe the relevance of underlying
factors to this behavior [24–28]. However, as justly referred by
2001P.M. Matos et al. / Biochimica et Biophysica Acta 1798 (2010) 1999–2012Martins et al. [29], caution must be exerted when comparing a 2D
reaction with a 3D counterpart, namely not disregarding the clause
“other factors being equal”. When going from 3D to 2D some factors
will face changes inherent to the reduction of dimensionality, as it
happens for the diffusion coefﬁcient. While there is RD enhancement
in most cases for reaction-limited processes, for diffusion limited
processes there is a disadvantage in conditions plausible to occur in
biological systems [10].
This review is focused on methods to monitor membrane
interaction that avoid chemical modiﬁcation of the peptides and
proteins involved in the study, as this may change their membrane
binding properties (e.g., [30,31]). This is achieved mainly by taking
advantage of the intrinsic ﬂuorescence of the peptides and the use of
membrane ﬂuorescent probes to indirectly monitor perturbations
caused by peptide interaction. However, it is important to mention
that in many cases of peptides that are not intrinsically ﬂuorescence,
the derivatization with a suitable ﬂuorophore can be a valuable
solution to measure their interaction with membranes, provided that
it does not signiﬁcantly alter the peptide structural and functional
properties. This labeling may also enable the use of other ﬂuores-
cence-based techniques, such as microscopy imaging and ﬂuores-
cence correlation spectroscopy (FCS) [32,33]. Moreover, this can also
be useful to obtain more insightful information regarding peptide
orientation in membranes [34,35].
2. Quantiﬁcation of the partition of a peptide to a membrane
using intrinsic ﬂuorescence
2.1. Basic concept
The partition constant or partition coefﬁcient of a solute between
an aqueous and a lipid phase can be deﬁned, based on the free energy
of transfer of the solute between the two phases, as:
Kp;x =
nS;L
nL + nS;L
nS;W
nW + nS;W
ð2Þ
where nW and nL are the moles of water and lipid, and nS,i are the
moles of solute present in each phase (i=W, aqueous phase; i=L,
lipid phase). As under most experimental conditions the quantities of
water and lipid are considerably higher than the quantity of solute on
the aqueous and lipid phases, respectively, the equation is usually
simpliﬁed to:
Kp;x≈
nS;L
nL
nS;W
nW
ð3Þ
However, in most of the literature the partition coefﬁcient is
presented as a function of the volumes of the phases, Vi, instead of
using the quantity of lipid and water:
Kp =
nS;L
VL
nS;W
VW
ð4Þ
This parameter, sometimes named Nernst partition coefﬁcient, can
be related with the previous one by the expression:
Kp = Kp;x
γW
γL
ð5Þ
where γi is the molar volume of water (i=W) or lipid (i=L).
A different way to describe the interaction of a solute with a
membrane is by considering a binding mechanism. In this case, a
chemical equilibrium between the solute and one or more lipid
molecules is considered, and a conventional binding isotherm isobtained (e.g., [36,37]), in which two parameters describe the
process: a dissociation constant, Kd (or an association constant) and
the number of lipid molecules that are associated with a solute
molecule. The main disadvantage of this option relatively to the
partition formalisms is that there is no molecular counterpart for
describing those binding sites in the membrane, as if some kind of
receptors for the solute would exist. In fact, the membrane is a
supramolecular system and the solute interaction is controlled by the
lipid ensemble.
The partition quantiﬁcation has been previously extensively
reviewed elsewhere [38], including the use of several optical
spectroscopies and non-optical techniques. Experimental artifacts,
practical limitations and the determination of membrane inter-
domain partitions are also discussed in that review.
2.2. Determination of Kp by intrinsic ﬂuorescence parameters
For most of the cases, the partition coefﬁcient of a molecule
between a lipid and an aqueous phase can be evaluated by
ﬂuorescence spectroscopy as long as: (i) there is a difference in a
ﬂuorescence parameter (e.g., quantum yield, ﬂuorescence anisotropy
or ﬂuorescence lifetime) of the partitioning molecule when in
aqueous solution and after incorporation in the membrane or, (ii)
the incorporation of the molecule in the membrane leads to a change
on a ﬂuorescence property of a membrane probe. The ﬁrst situation
will be treated in this section.
The intrinsic ﬂuorescence of peptides containing tryptophan (Trp)
or tyrosine (Tyr) residues is a valuable tool to quantify their insertion
on lipid membranes. Due to the strong dependence of the ﬂuores-
cence of these aromatic amino acids (specially Trp) on the physical
properties of their micro-environment, the insertion of the peptide on
a lipid membrane can lead to substantial changes on the quantum
yield, wavelength of the emission maximum, ﬂuorescence anisotropy
and ﬂuorescence lifetime [39].
As long as there is a signiﬁcant difference between the quantum
yield of the peptide in the aqueous environment and in the lipid
membrane, its partition constant can be determined by conducting
ﬂuorescence intensity, I, measurements with a ﬁxed concentration of
peptide and increasing lipid concentrations ([L]). This usually yields a
hyperbolic-like I vs. [L] variation proﬁle, which can be ﬁtted using
[40,41]:
I =
IW + KpγL L½ IL
1 + KpγL L½ 
ð6Þ
where γi is the molar volume of water (i=W) or lipid (i=L). Ideally, I
should be the integrated ﬂuorescence emission intensity but, if no
signiﬁcant spectral shifts occur upon increasing [L], Imay be measured
at a chosen emission wavelength. Typical examples of the use of this
equation on the quantiﬁcation of the interaction of peptides with
membranes are the studies of the lipid selectivity of the previously
mentioned different HIV-1 membrane fusion inhibitors [7,8,19].
To use the steady-state ﬂuorescence anisotropy, r, to calculate the
partition coefﬁcient of a ﬂuorescent molecule, it is not only necessary
that this parameter has a signiﬁcant change between the lipid and
aqueous phases, but also the ﬂuorescence intensity from both phases
must be comparable. Using an experimental design identical to that
indicated for the ﬂuorescence intensity-based methodology, the data
should be ﬁtted using [42]:
r =
rW γL L½ ð Þ−1−1
 
+ rLKpεLϕL = εWϕWð Þ
γL L½ ð Þ−1−1 + KpεLϕL = εWϕWð Þ
ð7Þ
where ϕ is the ﬂuorescence quantum yield and ε is the molar
absorption.
Fig. 3. Fluorescence emission intensity of pep-1 (6.88 μM), normalized by dividing by
IW, upon titration with large unilamellar vesicles of palmitoyloleoylphosphatidylcho-
line (POPC; circles; normal hyperbolic increase of I) or dipalmitoylphosphatidylcholine
(DPPC; squares; system where self-quenching occurs). Eqs. (6) and (15), respectively,
were used for data ﬁtting and Kp quantiﬁcation. Reprinted from [46].
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methodologies, partition coefﬁcients can also be obtained by time-
resolved ﬂuorescence spectroscopy. When carrying out a time-
resolved ﬂuorescence spectroscopic study of the interaction of a
ﬂuorescent molecule with a membrane system, ideally two
exponentials would describe the experimental ﬂuorescence inten-
sity decay, one corresponding to the molecules in aqueous media
and the other to the molecules in the lipid environment:
IðtÞ = aW expð−t = τWÞ + aL expð−t = τLÞ ð8Þ
(where t is time and τi is the ﬂuorescence lifetime of the molecules in
each phase). In this ideal case, the relative concentration of each
specie could be calculated from the pre-exponential factors ratio (aL/
aW), if the radiative rate constants and absorption coefﬁcient ratios in
both phases are known [43]. However, in most of the cases (including
intrinsically ﬂuorescent peptides), the decays both in the aqueous
phase and on the membrane are complex. Thus, the total decay must
be described by a sum of exponentials, mixing up all the contributions.
Therefore, an average of the ﬂuorescent lifetime should be used. The
average ﬂuorescence lifetime of a ﬂuorophore, bτN, is given by (e.g.,
[44]),
hτi =∑aiτ
2
i
∑aiτi
ð9Þ
However, if bτN is used for Kp determination, a complex equation
would be attained, where steady-state and transient-state data must
be combined [40]:
τh i = τh iW + τh iL− τh iW
  KpγL L½ 
KpγL L½  + εWϕWεLϕL
ð10Þ
Therefore, it is more convenient to calculate the variation of the
ﬂuorescence lifetime averaged by the pre-exponentials, Pτ,
Pτ =
∑aiτi
∑ai
ð11Þ
leading to the formalism for the determination of Kp [40],
Pτ =
PτW + KpγL L½ PτL
1 + KpγL L½ 
ð12Þ
This simpler equation is similar to Eq. (6) because both Pτ and I
are additive parameters. These cases can be assigned to the same
general equation [38]:
p =
pW + KpγL L½ pL
1 + KpγL L½ 
ð13Þ
where p stands for any additive parameter, such as I or Pτ. If
εWϕW≈εLϕL and γL[L]≪1 (a condition present in most experimental
conditions) are assumed in Eq. (7), then p may also stand for r.
2.3. Complex partition curves
As an exception to the general rule of the increase of I, r and τ of a
ﬂuorophore upon incorporation in a membrane system, Vermeir et
al. [45] reported a decrease on the ﬂuorescence intensity of the
partitioning molecule when in the membrane. This quenchingprocess was used as a simple methodology to obtain the value of
the partition coefﬁcient, by a linear ﬁt:
IW
I
= 1 + KpγL L½  ð14Þ
This equation is in fact a special case of Eq. (6) for a situation in
which it is assumed that IL=0. More recently, in a study of the
membrane and environmental parameters that inﬂuence the activity
of the cell-penetrating peptide pep-1 [46], a less strict model was
proposed to quantify the partition constants of systems in which
ﬂuorescence quenching (usually self-quenching) can occur upon
insertion in the membrane (Fig. 3):
I =
KpγL L½ IL
1 + KpγL L½  + k2KpIL
+
IW
1 + KpγL L½ 
ð15Þ
where,
k2 =
kq
εlkf
ð16Þ
l is the optical path, kq is the kinetic constant of the quenching process,
kf is the radiative ﬂuorescence constant and ε is the molar absorption.
Pina et al. adapted this model to a more complex and speciﬁc
situation, in which there is a combined effect of the partition of the
Shiga toxin B-subunit to the bulk lipid membrane, with self-
quenching, and the subsequent binding of the protein to its speciﬁc
ligand (a glycolipid) with an increase on the quantum yield [47].
Other types of deviations from the normal hyperbolic behavior of
partition curves were reported on the study of the interaction of the
antimicrobial peptide omiganan with biomembrane model systems
with different lipid compositions [3]. Upon titration of the peptide
solution with some of the lipid vesicles, a spike was registered,
deviating from the hyperbolic-like behavior just on a restrict range of
lipid concentrations (Fig. 4). This critical-point was explained by a
model, tested by curve simulation, where a sequence of events is
taken into account, in which it is considered that the apparent Kp is
dependent on peptide concentration: ﬁrstly, at high peptide/lipid
ratios, a saturated regime in which the local concentration of the
peptide in the membrane is constant and independent of the
concentration of the peptide in solution. In this situation, the constant
parameter that describes the system, instead of Kp, is the local
peptide/lipid ratio in themembrane, σ. Secondly, at low peptide/lipid
ratios, the excess of lipid enables the use of the previously described
common partition formalisms, with a constant Kp. On the critical-
Fig. 4. Partition curves of the antimicrobial peptide omiganan to lipid vesicles of
palmitoyloleoylphosphatidylglycerol (POPG; triangles) and dipalmitoylphosphatidyl-
glycerol (DPPG; circles). Fluorescence emission intensities were normalized by dividing
by IW. The peptide concentration was 7.7 μM. Reprinted from [3].
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can be identiﬁed from the partition curves experimentally obtained
with different peptide concentrations and ﬁtted by:
P½ s =
σ
KpγL
+ σ L½  ð17Þ
where [P]s is the peptide concentration at the saturation point for a
concentration of lipid, [L]. On a study of the membrane insertion of a
possible dengue virus fusion peptide [48], the use of this formalism
was further extended to systems in which peptide oligomerization
occurs, driven by its local high concentration in the membrane, but
not strictly resulting from saturation (Fig. 5).Fig. 5. Partition of a possible dengue virus fusion peptide to lipid vesicles of POPC:POPG
(4:1) at pH 5.5 (ﬁlled squares) and pH 8.0 (open squares). Fluorescence emission
intensities were normalized by dividing by IW. The peptide concentration was 18 μM.
Reprinted from [48].2.4. Adsorption quantiﬁcation by Förster Resonance Energy Transfer
methodologies
As previously shown, the evaluation of the interaction of
ﬂuorescent peptides and proteins with lipid membranes can be easily
followed by recording the changes on the ﬂuorescence properties of
the aromatic amino acid residues. Nevertheless, generally, the
adsorption of peptides or proteins on the surface of lipid membranes
will not induce signiﬁcant changes in the ﬂuorescence parameters or
will lead to changes not large enough to allow a correct determination
of a partition coefﬁcient. Therefore, it can be advantageous to follow
the interaction of ﬂuorescent peptides with lipid membranes adding
molecules that will perturb the ﬂuorescence properties of the
aromatic residues of the peptides. Simple dynamic quenching
approaches, as recently described [49], or even Förster Resonance
Energy Transfer (FRET) methodologies can be used with this purpose.
For instance, FRET methodologies can be a quite powerful approach,
yielding information about the extent and the topological range of the
molecular interaction of peptides with membranes [39,44].
FRET is the process in which a molecule in the excited state
(donor) returns to the ground state by transferring its energy to
another molecule (acceptor) without the emission of a photon or
contact between molecules. The extent of the energy transfer is
determined by the distance between donor and acceptor and the
overlap of the donor's ﬂuorescence emission spectrum and the
acceptor's adsorption spectrum [39]. An important parameter to
describe this phenomenon is the Förster radius, R0, which can be
calculated from the spectroscopic data of the donor and acceptor,
using:
R0 = 0:2108 κ
2ϕDn
−4J
h i1=6 ð18Þ
where κ2 is a factor that depends on the relative orientation of donors
and acceptor (the value κ2=2/3, relative to the dynamic isotropic
limit, is usually assumed [50]), ϕD is the donor quantum yield in the
absence of the acceptor and n is the refractive index (n=1.4 is used as
refractive index within lipid vesicles [51]). The parameter J represents
the spectral overlap integral between the emission spectrum of the
donor and the absorption spectrum of the acceptor:
J = ∫
∞
0
I λð Þε λð Þλ4dλ ð19Þ
where I(λ) is the normalized donor emission spectrum and ε(λ) is the
acceptor molar absorption spectrum, in the interval of wavelengths
centered in λ and with width dλ. The numerical constant in Eq. (18)
implies the use of λ is in nm, ε in M−1 cm−1, and R0 in Å.
The efﬁciency of energy transfer, E, is deﬁned as the fraction of the
energy of the photons absorbed by the donor that is transferred to the
acceptor, and is given by,
E =
kT
kT + τ
−1
D
=
R60
R60 + R
6 ð20Þ
kT represents the rate of energy transfer from a donor to an acceptor
separated by a distance R. Therefore, the Förster radius, R0, represents
the distance for which the efﬁciency of energy transfer is 0.5.
Experimentally, the efﬁciency of energy transfer, E, can be calculated
using the equation:
E = 1−
PτDA
PτD
= 1− IDA
ID
ð21Þ
where PτDA and
PτD are the ﬂuorescence lifetimes averaged by the pre-
exponential factors (Eq. (11)) and IDA and ID are the ﬂuorescence
Fig. 6. Detection of peptide binding to the membrane by FRET. Fusion inhibitors enfuvirtide (A) or C34 (B) at 0.45 μM, were added to phosphatidylcholine/phosphatidylserine/
cholesterol/DNS-phosphatidyletanolamine (8:8:2:1 (w/w), 68 μM) lipid vesicles. Excitation at 280 nm and emission at 518 nm. Reprinted from [54].
Fig. 7. Detection of the binding of T-1249 to cholesterol-enriched membranes by FRET.
(A) Diagram representing the donor–acceptor geometry in the lipid bilayer: T-1249
adsorbed at the surface and DHE in both leaﬂets of the membrane. (B) Energy transfer
efﬁciency from Trp residues of T-1249 (donor) to DHE (acceptor) in POPC/cholesterol
vesicles. The boundaries AW=0.2 and AW=0.4 are also represented (dashed lines).
Reprinted from [7].
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acceptor, respectively.
Here, we will use the interaction of HIV gp41 derived peptides
with lipid bilayers to illustrate FRET applications on the quantiﬁcation
of adsorption. The HIV fusion process mediated by the gp120–gp41
complex occurs in an extreme conﬁnement between the viral
envelope and the cell membrane [52]. The ability of certain domains
and regions of these proteins to interact withmembranes is important
for various steps of the entry and even for the inhibition of the fusion
process. As previously referred, some HIV gp41 derived peptides have
a peculiar interaction with lipid model systems, which can be related
to their molecular mode of action [7,8,19]. In all the examples that will
be given, the donor groups are the Trp residues of the peptides,
whereas the acceptor molecules are localizedwithin the lipid bilayers.
Kliger et al. studied the binding of a recombinant protein
corresponding to the ectodomain of gp41 [53] and HIV-1 fusion
inhibitor peptides (enfuvirtide and C34 [54]) with lipid membranes
by measuring the energy transfer from the Trp residues of these
proteins and peptide to dansyl (DNS) chromophores incorporated
into lipid vesicles. They detected the binding by measuring the
increase in the sensitized DNS ﬂuorescence emission upon excitation
of Trp (Fig. 6).
Other studies using ﬂuorescence spectroscopy methodologies
[7,8,19] found a correlation between membrane-interaction proper-
ties of HIV fusion inhibitor peptides and their efﬁcacy. The adsorption
of T-1249 to cholesterol-rich membranes and the adsorption of
sifuvirtide to DPPC gel phase membranes were demonstrated by
several ﬂuorescence approaches and conﬁrmed by FRET, using as
acceptors dehydroergosterol (DHE), an intrinsically ﬂuorescent
cholesterol analogue, and 1,6-diphenylhexatriene (DPH), a rigid
rod-like ﬂuorescent probe that partitions deeply within the core of a
lipid bilayer [55], respectively.
Using a speciﬁc FRET methodology to describe the adsorption
events, it was possible to quantify the fraction of molecules that was
adsorbed on the surface of the bilayers. The formalism [7,19,51]
assumes several planes parallel to the bilayer surface (Fig. 7A): two
acceptor planes and a donor plane (Trp residues) at a distanceWi from
that of the acceptors, in the case of T-1249, for instance. Firstly, the
decay of the donor ﬂuorescence intensity in the absence of acceptor is
given by:
ID tð Þ = AWID;W tð Þ + 1−AWð Þ⋅ID;L tð Þ ð22Þ
where ID,W and ID,L are the ﬂuorescence decays of the donor in the
buffer and adsorbed to the lipid vesicles, respectively, and AW is the
fraction of the molecules in aqueous solution. For T-1249 in the
presence of the acceptor in the membrane, the ﬂuorescence decay ofthe sub-population in solution is not affected, but the adsorbed
donor's ﬂuorescence is extinct by acceptors localized in two parallel
planes (Fig. 7A). The donor ﬂuorescence decay, in the presence of the
acceptor is:
ID;A tð Þ = AWID;W tð Þ + 1−AWð Þ⋅ID;L tð Þ⋅ρ1 tð Þ⋅ρ2 tð Þ ð23Þ
The ρi(t) functions denote the FRET rates to acceptors located on
the planes W1 and W2 away from the donor, respectively, and are
given by [51]:
ρi tð Þ = exp −2
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Fig. 8. Putative modes of action at the membrane level of T-1249 and sifuvirtide,
revealed after combining overall partition and more detailed FRET approaches. (A)
Schematic representation of the involvement of lipid membranes in T-1249 inhibition
mechanism, as described in [7], displaying the adsorption on cholesterol-enriched
membrane domains. The translocation of the peptide is prevented due to charge
repulsion of negatively charged phospholipids of the inner leaﬂet. The term raft refers
to cholesterol-rich liquid-ordered membrane microdomains. (B) Schematic represen-
tation of the adsorption of sifuvirtide on the surface of DPPC gel phase membranes in
the presence of physiological NaCl concentration, as described in [49]. Reprinted from
[7,49].
Fig. 9. Schematic representation of the three types of membrane potential by tracing
the electrical potential proﬁle across the membrane. Surface potential (ψs) arises from
the accumulation of charges at the membrane surface. Dipole potential (ψd) derives
from the sum of the dipolar components of the phospholipids and interface water. Ion
concentration gradients account for transmembrane potential (Δψ). Reprinted from
[57].
2005P.M. Matos et al. / Biochimica et Biophysica Acta 1798 (2010) 1999–2012where n is the acceptor density (molecules/unit area), which was
computed from:
n =
½DHE
½POPC⋅ aPOPC + 12 achol−b
  ð25Þ
where aPOPC and achol are the areas per POPC and the cholesterol
molecule on the bilayer plane, respectively, and b is the condensation
effect of cholesterol on the bilayer area. In this equation, the area of
cholesterol is divided by 2 due to the fact that the POPC:cholesterol
mixture ratio used in that original work was 2:1. R0 was calculated
using Eq. (18) and the FRET efﬁciency according to Eq. (21), where ID
and IDA were obtained by the numerical integration of the theoretical
decay laws:
ID = ∫
∞
0
iD tð Þdt ð26Þ
ID;A = ∫
∞
0
iD;A tð Þdt ð27Þ
AW, was obtained from the non-linear regression analysis of
experimental data (Fig. 7B). It is worth of notice that the interactions
of T-1249 and sifuvirtide with the lipid vesicles for which there is
peptide adsorption were difﬁcult to quantify by the ﬂuorescence
spectroscopy approaches mentioned in the previous sections, because
these peptide–membrane interactions only cause minor changes inthe Trp ﬂuorescence parameters [7,19]. Overall, the use of a FRET
methodology allowed retrieving detailed information (Fig. 8) and
revealed a correlation between the efﬁcacy and membrane domain
selectivity among HIV fusion inhibitor peptides [7,19].
3. Peptide–lipid interactions studied using membrane
potential-sensitive probes
In many cases, it is not possible to rely on the intrinsic ﬂuorescence
of peptides or proteins due to the lack of ﬂuorescent amino acids.
Moreover, on the study of cell systems, interference of other cellular
proteic components makes Trp and Tyr ﬂuorescence a useless tool.
However, when a molecule is interacting with a lipid membrane, it
alters some of the intrinsic properties of the membrane, such as the
different types of membrane potentials, lipid ﬂuidity, curvature,
polarity or packing. Lipophilic ﬂuorescent probes sensitive to these
properties can be used to indirectly report parameters of protein–
membrane or peptide–membrane interactions. We will focus on the
use of potential-sensitive ﬂuorescent probes, as ﬂuidity and polarity
probes are more commonly used to study membrane properties
themselves [56]. This strategy also avoids the necessity of peptide or
protein derivatization, which can modify native structures and lead to
biased results. This advantage is particularly important when peptides
are used. The use of these probes has also been recently reviewed
elsewhere [57].
3.1. Membrane surface potential perturbation
The surface potential is a consequence of the net excess charges
that accumulate in the outer surface of the cell membrane, in contact
with the external medium (Fig. 9). It is therefore the potential
difference between the membrane surface and the bulk medium. The
sources of these charges are mainly ionized lipid head-groups and
ions electrostatically interacting with them [58–60]. Hence, the
approach of a charged entity, such as a peptide or protein, to the
membrane outer surface is likely to alter the surface potential by itself
or altering the ion distribution.
Fluorescein phosphatidylethanolamine (FPE) has been the main
probe used to detect alterations in the membrane surface potential
[61].When incorporated into lipidmembranes, the ﬂuoresceinmoiety
of this probe stands precisely in the water–lipid interface, and hence it
has the ability to detect pH or charge distribution changes at the
membrane surface (Fig. 10) [61]. FPE behavior can be explained by the
Fig. 10. Structural representation of different potential sensitive probes in the membrane leaﬂet environment. FPE and di-8-ANEPPS are the main probes for use in the detection of
surface and dipole potential, respectively. DiSC3(5) is depicted as an example of slow response transmembrane potential probe that partitions to themembrane. The structures of the
probes are represented as inserted in a portion of a phosphatidylcholine (PC) lipid layer.
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potential [62]:
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cF
cHF
 
= pH− pK− Fψs
RTln10
 
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where cF and cHF are the concentrations of the dissociated and
protonated forms of the ﬂuorophore located at themembrane surface,
respectively, and the expression pK−Fψs/(RT∙ln10) is the apparent
pK, where ψs is the surface potential. Changes in the surface potential
at constant bulk phase pH affect the apparent pK of FPE and,
consequently, its protonation state, resulting in changes in the
quantum yield [61,62]. The simplest test to verify the correct
incorporation and responsiveness of FPE in vesicles or cells is the
addition of calcium ions (cation to which the membranes are
impermeable) to the medium, which will lead to an increased surface
potential (accumulation of positive charges at the surface) and,
consequently, decreased ﬂuorescein apparent pK, increased deproto-
nation and increased ﬂuorescence intensity [61]. This effect is
observed not only for negatively charged phospholipids that attract
the calcium ions, but also for the zwitterionic ones, which complex the
calcium ions via the phosphate groups [63,64] or even possibly
through the carbonyl oxygens [65]. The dielectric environment
appears not to inﬂuence signiﬁcantly the probe [66]. However, this
is a possible interference factor, as protein adsorption may alter the
dielectric environment of the probe and not only the surface potential.
As a lipophilic dye, FPE is suitable for labeling both lipid vesicles
and cell membranes. Lipid vesicles are usually obtained by extrusion
methods, and the incorporation of FPE can be done by two different
experimental approaches: (i) co-solubilizing the probe in the lipid
mixture prior to the extrusion, or (ii) labeling the vesicles after they
are formed, by incubating them with the probe, followed by gelﬁltration to remove unbound ﬂuorophore [61]. The ﬁrst option is a
simpler and faster method, but both inner and outer leaﬂets of the
bilayers get labeled. In most of the cases where just the interaction
with the outer leaﬂet is concerned, the labeled inner leaﬂet does not
interfere (provided that translocation of the interacting molecule to
the vesicle interior and changes in the inner leaﬂet environment are
not signiﬁcant). Cell membranes can be easily labeled by incubating
them with FPE. There is no need for gel ﬁltration, as the unbound
probe can be removed by centrifugation and washing with fresh
buffer. In some speciﬁc cases of its application to studies with cells, the
response of FPE may not be the expected due to complex membrane
features, such as the extensive glycocalix in erythrocytes [67,68] or
the extracellular matrix of B12 microglial cells [67]. Successful FPE
changes could be observed after treatment with neuraminidase and
collagenase, respectively, to remove such features.
The interactions of the peptides melittin (component of the bee
venom) and p25 (leader sequence of subunit IV of cytochrome c
oxidase) with membrane model systems were among the ﬁrst
experiments to use FPE as surface potential reporter [61]. When p25
or melittin was added to a FPE-labeled vesicles suspension, an
immediate increase of ﬂuorescence intensity was observed as a
consequence of their overall positive charge, followed by a slower
decrease in ﬂuorescence until stabilization. This biphasic response
was better observed using stopped-ﬂow rapid mixing method, as it
allowed resolving the initial ﬂuorescence increase event in the
millisecond time scale [61,69]. The most plausible explanation for
this kinetic proﬁle, advanced by the original authors, is that the
cationic peptide reaches themembrane surface, increasing the surface
potential and consequently the probe ﬂuorescence. After that, a
partial insertion into the membrane would bury positive charges,
which would no longer contribute to the potential and hence a
ﬂuorescence decrease would be observed. The dependence of FPE
Fig. 11. Interaction of ﬁbronectin with osteoblast membranes. (A) FPE-labeled osteoblasts ﬂuorescence intensity variation proﬁle with concentration, upon serial addition of
ﬁbronectin. A typical time course variation of ﬂuorescence intensity at the addition moment is shown in the inset. The data was ﬁtted to a single binding site model. (B) Heparitinase
treatment reduced the binding signiﬁcantly. Comparison of the ﬂuorescence changes between FPE-labeled osteoblasts (○) with those previously treated with heparitinase (□) that
removes cell surface heparan sulfate. The experiments were conducted at 37 °C with a cell concentration of 5×104/mL. Reprinted from [71].
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a cooperative binding model, never demonstrated before for a free
signal-sequence peptide [69].
The prion protein (PrP) is a cell membrane-associated protein that
can be converted, via post-translational modiﬁcations, to a pathogenic
scrapie form, which causes spongiform encephalopathies [70].
Interaction with membranes can have a role in this conversion. The
binding of Syrian hamster prion protein, which closely resembles
human prion protein, to biomembrane model systems was assessed
with FPE [70]. The interaction with POPG vesicles follows a complex
kinetic in which a rapid ﬂuorescence intensity increase is observed
due to initial interaction events, followed by a ﬂuorescence decrease,
probably due to protein partial insertion, and a third slower phase of
less perceptible ﬂuorescence increase, hypothesized as being caused
by lipid rearrangements. However, for the POPC:POPG mixture 70:30
(molar ratio), only the initial binding phase was observed, but with a
slower kinetics. This is an example of how FPE can dissect the different
stages of a peptide–membrane interaction.
FPE was also used to study the interaction between the
extracellular matrix protein ﬁbronectin and the membranes of
osteoblast, cells responsible for bone formation [71]. Upon addition
of ﬁbronectin to FPE-labeled osteoblasts, an immediate increase on
ﬂuorescence is observed (Fig. 11A, inset), revealing that an interaction
occurred rapidly. These ﬂuorescence variations were analyzed as a
function of protein concentration, enabling the calculation of a
dissociation constant (Kd) of 120 nM. The treatment of these cells
with heparitinase previously to the interaction experiments lead to a
50% decrease in binding (Fig. 11B), indicating that cell surface heparan
sulfate proteoglycans are partly responsible for the binding. More-
over, in the presence of the integrin-binding motif RGD peptide,
ﬁbronectin membrane binding was also reduced, due to competition
with integrin receptors. Therefore, ﬁbronectin appetence for osteo-
blasts is modulated by cell surface integrins and proteoglycans.
3.2. Membrane dipole potential perturbation
Dipole potential is another type of membrane potential, originat-
ing from the sum of the dipolar residues of lipids (polar head-groups
and glycerol-ester regions) due to its rather aligned organization and
oriented water molecules hydrating the surfaces of the membrane
(Fig. 9) [72,73]. Macromolecules interacting with the membrane can
destabilize this organization and/or contribute with their own dipoles
to the membrane dipole potential; hence, the detection of alterations
on this property can be used to report such interactions. The ﬁrst
ﬂuorescent membrane probes described as sensitive to dipole
potential were di-8-ANEPPS (4-[2-[6-(dioctylamino)-2-naphthale-
nyl]ethenyl]-1-(3-sulfopropyl)-pyridinium) [74] and RH421 (N-(4-sulfobutyl)-4-[4-[4-(dipentylamino)phenyl]butadienyl]-pyridinium)
[75]. They possess a considerably conjugated chromophore region
(high stokes shift) in which two aliphatic chains are attached to
facilitate the incorporation of the probe in a phospholipid layer. The
chromophore stays near the lipid head group and glycerol backbone,
sensing the local electric ﬁelds derived from the dipoles [74]. The
mechanism by which di-8-ANEPPS and RH421 sense the dipole
potential is believed to be electrochromical [76]. Absorption and
emission peaks shift in response to a nearby electrical ﬁeld that
differentially interacts with the ground-state and excited-state dipole
moments of the chromophore [77]. Thus, changes in dipole potential
are measured in terms of spectral shifts of the lipid bilayer
incorporated probe. Therefore, this type of probes is specially suitable
for a dual wavelength ratiometric measurements strategy, similar to
what is done with some ion indicators, such as for Ca2+ [78]. This
approach is very advantageous because the signal is independent of
probe or cell concentration and avoids photobleaching-induced
artifacts [74].
In this section, we present some examples regarding only the use
of di-8-ANEPPS, as it is the most commonly used dye for dipole
potential-related interaction studies (Fig. 10). Although the vast
majority of the work conducted with di-8-ANEPPS relies on the
measurement of excitation spectrum shifts, only recently a systematic
study was carried out to compare excitation and emission ratiometric
ﬂuorescence methods for this dye, concluding that only the former
can be used [79]. Shifts in the excitation spectra can be better
observed by transforming data in differential spectra, that is,
subtracting the normalized excitation spectra of the probe without
the molecule of interest from the normalized excitation spectra of di-
8-ANEPPS in the presence of the interacting molecules. This typically
yields a sinusoidal curve crossing the abscissa axis with onemaximum
and one minimum. A blue shift is denoted when the minimum occurs
at a lower wavelength than themaximum and the opposite for the red
shift. However, one has to know what this means in terms of dipole
potential variation. This is revealed bymodulating the dipole potential
of phospholipid vesicles with phloretin and 6-ketocholestanol (6-KC)
[74], previously shown to decrease and increase the membrane dipole
potential, respectively [80]. A blue shift is induced by 6-KC, meaning
that blue shifts indicate the increase in dipole potential, and the
opposite for phloretin. In addition, the ratio of the ﬂuorescence
intensity produced at the wavelengths of the maximum and
minimum of the differential spectra (the value at lower wavelength
divided by the value at higher wavelength) is a quantitative
parameter that can be used for the same purpose. Addition of 6-KC
to di-8-ANEPPS labeled vesicles increased the ratio, while such
parameter was decreased by phloretin [74]. To summarize, increasing
the dipole potential leads to a blue shift in the excitation spectrum and
Fig. 12. Sensing the membrane dipole potential with di-8-ANEPPS. The excitation spectrum of membrane-bound di-8-ANEPPS shifts in response to changes in the dipole potential.
The differential spectra help to visualize these shifts and to determine the wavelengths of maximal variation, in order to deﬁne the ratio R.
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leads to a red shift and decrease of the ratio (Fig. 12).
A problem that may arise is the fact that di-8-ANEPPS, as other fast
response voltage sensitive probes, is also sensitive to transmembrane
potential variations [81] and hence it is advised that, during
measurements, transmembrane potential, if any, should be kept
constant. Membrane ﬂuidity is another aspect for concern. Gross et al.
[74] stated that membrane microviscosity does not signiﬁcantly
inﬂuence the ﬂuorescence excitation ratio, and Clarke and Kane [82]
suggested that, in order to eliminate the possible effects of membrane
ﬂuidity, ﬂuorescence should be detected at the red-edge of the
emission spectra.
The inﬂuence of dipole potential on p25 interaction with lipid
vesicles was studied with di-8-ANEPPS, along with the above
mentioned FPE measurements for surface potential [83]. This peptide
induced a decrease in the dipole potential of phosphatidylcoline lipid
vesicles, as evaluated by the di-8-ANEPPS differential spectrum. The
excitation ratio of this probe was also measured for different
concentrations of p25, yielding a Kd of 2.8 μM. The initial dipole
potential of lipid vesicles was also modulated via phloretin or 6-KC,
changing the maximum extension of binding for the peptide. These
results, together with those from stopped-ﬂow ﬂuorescence mea-
surements with FPE, elucidated that p25 rapidly interacts with the
membrane surface before inserting into the membrane, affecting the
dipole potential only in this latter step.
The propensity of HIV-1 fusion inhibitor peptides enfuvirtide and
T-1249 to interact with blood cell membranes was also evaluated
using di-8-ANEPPS, as a Trp ﬂuorescence-based approach would be
impracticable with cells [84]. Human isolated erythrocytes and
peripheral blood mononuclear cells with their membranes labeled
with the probe were incubated with either one of the peptides.
Differential excitation spectra were obtained in order to observe the
probe response, showing that the presence of the peptides decreased
the dipole potential of the membrane in a concentration-dependent
manner (Fig. 13A). The kinetics of this interaction could be followed
by measuring the excitation ratio in real-time (Fig. 13B). To quantify
the afﬁnity of these peptides to the cell membranes, the variation of
the ratio with the peptide concentration was analyzed using a
hyperbolic binding curve, in order to obtain the peptide–biomem-
brane dissociation constants (Fig. 13C). T-1249 was shown to have an
approximately eight-fold higher afﬁnity when compared with
enfuvirtide. This enhanced interaction of T-1249 with cell membranes
correlates with its higher efﬁcacy in vivo, due to a possible effect of
membrane-enhanced drug transfer to the membrane-associated gp41
in its pre-fusion conformation.Besides di-8-ANEPPS, other probes have been shown to be
sensitive to dipole potential. Variants of NBD-labeled lipids were
tested for their sensitivity to membrane dipole potential [85]. The
probes relative ﬂuorescence intensity had a linear dependency on the
dipole potential of the labeled vesicles. No shifts or broadening of the
probe spectrum were observed when the dipole varied; hence, no
ratiometric approach can be used. Probes derived from 3-hydroxy-
ﬂavone, such as F4N1 (N-[(4′-dimethylamino)-3-hydroxy-6-ﬂavonyl]
methyl-N,N-trimethyl ammonium bromide) and BPPZ (3-(4-{4-[4′-
(3-Hydroxybenzo[f]ﬂavonyl)phenyl]piperazino}-1-pyridiniumyl)-1-
propanesulfonate), were more recently developed [86]. These probes
have the particularity of undergoing excited-state intramolecular
proton-transfer (ESIPT), yielding two tautomeric forms, revealed by
the presence of two peaks on their ﬂuorescence emission spectra.
Excitation spectrum shifts were observed for both probes and, more
importantly, the intensity ratio of the two emission bands also
changed as a response to potential variations. These two types of ratio,
at two wavelengths of the excitation spectrum edges and at the two
emission peaks, correlated very well with di-8-ANEPPS excitation
ratio, proving the usefulness of these new probes for detecting dipole
potential. The two-band emission ratio is also very useful for
microscopy, as the emissions can be collected from two emission
ﬁlters corresponding to the bands, enabling the production of ratio
images.
3.3. Transmembrane potential perturbation
The transmembrane potential can be deﬁned, in simple terms, as
the difference of potentials between the intra and extracellular
aqueous phases. This is a consequence of the selective nature of the
membrane, which may allow the ﬂux of speciﬁc charged solutes (e.g.,
ions), creating a concentration gradient (Fig. 9).
There are many ﬂuorescent probes available to detect changes in
the transmembrane potential. They can be divided in two major
groups, depending on their slow or fast response [87]. The slow
response probes include carbocyanins, such as its indo-(DiI), thio-
(DiS) and oxo-(DiO) derivatives, and oxonols, including bis-barbituric
acid (DiBAC) and bis-thiobarbituric acid (DiSBAC) derivatives. The
mode of detection of this type of probes may vary depending on the
molecule, but it is often based on the partition equilibrium between
the membrane and the aqueous medium, or through a Nernst
equilibrium-dependent translocation to the cell or mitochondria
interior [88]. On the other hand, fast response probes (that include
ANEP and RH families) sense potential alterations by electrochromic
mechanisms and intramolecular charge rearrangements, as
Fig. 13. Interaction of HIV fusion inhibitor peptides with erythrocyte membrane. (A) Differential spectra showing the dipole potential changes in the presence of enfuvirtide or T-
1249. (B) The decrease in the dipole potential when the peptides are added can be followed through time by measuring the ratio (R) of ﬂuorescence intensities (I) at two excitation
wavelengths of maximum variation according to the differential spectra, R= I455nm/I525nm. (C) Quantiﬁcation of the afﬁnity of the two peptides towards the erythrocyte membrane
by ﬁtting the data to a hyperbolic binding model (single binding site). T-1249 dissociation constant (4.16 μM) is approximately eight times lower than for enfuvirtide (35.4 μM). For
peripheral blood mononuclear cells the variation trend was similar. Ratios were normalized for the initial value. Adapted from [84].
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much faster than molecular translocations, justifying the
nomenclature.
The monitoring of alterations in transmembrane potential during
the interaction of macromolecules with membranes is important in
cases where major membrane destabilizations (such as pore forma-
tion or loosening of the lipid matrix) take place, dissipating ionic
gradients. The most representative examples are from antimicrobial
peptides, which often form pores or channels in bacterial membranes,
in order to induce leakage and, consequently, cell death. Additionally,
cell-penetrating peptides, able to translocate cargo molecules inside
the cell without major membrane disruption, can depend on
transmembrane potential for their mode of action [30,89].The antimicrobial family of microcins consists of low molecular
weight peptides synthesized mainly by Escherichia coli [90]. The
interaction of the peptide Microcin J25 (MccJ25) with membrane
vesicles was assessed by various methods, including transmembrane
potential monitoring with the slow response probe DiSC3(5) (3,3′-
dipropylthiadicarbocyanine iodide, Fig. 10) [91]. A transmembrane
potential was achieved by adding valinomycin to vesicles prepared in
a KCl-containing buffer and suspended in a NaCl-containing buffer. In
the presence of MccJ25, the preformed potential is signiﬁcantly
dissipated, as indicated by an increase in the ﬂuorescence of the
probe, both for vesicles of PC and PC/PG/CL (phosphatidylcoline/
phosphatidylglycerol/cardiolipin), a mixture that mimics bacteria
membrane (Fig. 14). Therefore, it was shown that the peptide is
Fig. 14. Perturbation of lipid membranes by the antimicrobial peptide microcin J25.
Transmembrane potential monitoring with the probe DiSC3(5) for K+-loaded lipid
vesicles of PC (solid line) or PC:PG:CL 7:2:1 (dotted line) in Na+-containing buffer.
Addition of valinomycin induced a transmembrane potential that was dissipated with
the addition of the peptide. Reprinted from [91].
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done with the rationally designed peptide PST11-RK, based on the
structural motifs of the antimicrobial peptide tritrpticin. The effect
that this peptide has on bacterial membranes was assessed via DiSC3
(5) ﬂuorescence for Staphylococcus aureus and E. coli [92]. In the
presence of PST11-RK, a ﬂuorescence increase was observed due to
bacterial membrane depolarization (dissipation of potential) in a
concentration-dependent manner. Membrane permeabilization
should then represent a major killing factor upon PST11-RK
application.
4. Conclusions
Visualizing, monitoring and understanding biological and biophy-
sical processes in real-time are of key importance for life sciences
research. Focusing on processes that occur at the cell membrane level,
it has been described how intrinsic features of peptides and proteins,
namely ﬂuorescence, can help to observe their behavior towards this
important cell structure.
The interaction of proteins or peptides with the cell membrane or
membrane model systems can be conveniently followed using
ﬂuorescence spectroscopy. This can be regarded simply as a
qualitative tool, but themain advantages of ﬂuorescence spectroscopy
application at this level are related with its use for quantitative
purposes, on the direct evaluation of peptide–membrane and
protein–membrane interactions, together with the elucidation of
the factors that inﬂuence the extension of the process. The changes in
some of the intrinsic ﬂuorescence parameters of peptides containing
ﬂuorescent amino acid residues can be easily used to measure the
insertion of a peptide on a membrane, without the need of peptide
labeling (a process that can lead to signiﬁcant changes on thestructure and properties of the molecule and consequent biased
observations). Additionally, the ﬂuorescent amino acid residues of a
protein can also be used as energy transfer donors, enabling the
quantiﬁcation of the extension even of the weak interactions
associated with most of the membrane adsorption processes.
Many studies are centered in the interacting macromolecule,
meaning that it is such the entity that produces the ﬂuorescence
signal, whether it has intrinsic ﬂuorescent amino acid residues or it is
derivatized with a ﬂuorophore. However it can be more advantageous
to perform membrane-centered studies, in which a property of the
membrane is monitored by means of a lipophilic ﬂuorescent probe
while the interaction is occurring. We reviewed how probes sensitive
to the different types of membrane potential can translate such
interactions. FPE is the main probe sensitive to surface potential and
can report interactions of charged macromolecules with the mem-
brane surface. It is capable of distinguishing different moments of
interaction, such as initial binding events and insertion, allowing
multiphasic kinetics to be observed. The membrane dipole potential
sensor di-8-ANEPPS detects interactions of molecules that do not
need to be charged and is particularly sensitive to molecules rich in
dipole chemical groups. It reports insertions in the lipid layer or
surface interactions that disturb the organizations of dipolar residues
of the phospholipids. Transmembrane potential probes are useful to
assess interactions that lead to membrane disruption, causing
potential dissipation and eventually content leakage or lysis. Real-
time imaging with membrane potential sensitive probes is becoming
a reality and it will be very interesting to follow the evolution of these
techniques to enable the mapping of interaction events at the
membrane level.
Several studies use more than one of these experimental
approaches in order to obtain more information about the interaction
events. All these methodologies, as well as their combination provide
molecular level information useful in the ﬁelds of drug development,
cell signaling, trafﬁcking and interactomics.Acknowledgments
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